ReviewSeminars in oncology2012

p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.

Yogen Saunthararajah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.